Related Experiment Video
Updated: Dec 28, 2025
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.8K
Benzodiazepine Use and Cognition in the Elderly
Amber R Toombs1, Joon Y Jung1, Nicole D White1
1Creighton University School of Pharmacy and Health Profession, Omaha, Nebraska.
American Journal of Lifestyle Medicine
|February 18, 2020
Summary
Benzodiazepines may increase cognitive decline risk in older adults with insomnia. Patient education and lifestyle changes are vital for safe insomnia management in the elderly.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Neurology
Background:
- Benzodiazepines are frequently prescribed for insomnia in elderly patients.
- This population faces heightened risks from benzodiazepine use, including cognitive impairment.
- Understanding these risks is crucial for geriatric care.
Purpose of the Study:
- To examine the link between benzodiazepine use and cognitive decline in the elderly.
- To emphasize the importance of patient education for safe benzodiazepine prescribing.
- To explore non-pharmacological interventions for insomnia in older adults.
Main Methods:
- Literature review of studies on benzodiazepine use and cognitive function in the elderly.
- Analysis of risk factors and patient education strategies.
- Discussion of lifestyle modifications for insomnia management.
Main Results:
- Benzodiazepine use is associated with increased risk of cognitive decline in older adults.
- Effective patient education can mitigate risks and improve adherence.
- Lifestyle modifications offer a safer alternative or adjunct treatment for insomnia.
Conclusions:
- Careful consideration of benzodiazepine risks is essential in elderly insomnia patients.
- Prioritizing patient education and non-pharmacological approaches is recommended.
- Further research into long-term cognitive effects and alternative treatments is warranted.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
147
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
147
01:15Drug Dosing: Geriatric Patients
174
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
174
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
664
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
664
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
2.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.2K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
456
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
456